Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00172055
Status:
COMPLETED
Last Update Posted:
2017-03-06
First Post:
2005-09-13
Brief Title:
Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss CTIBL in Patients With Prostate Cancer on Hormone Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis